Two-year interim results from a 5-year study evaluating clinical recurrence o... - 0 views
-
The proportion of subjects who were clinically clear at the 2-year follow-up visit was estimated to be 82.0%. Imiquimod was tolerated when applied daily, with erythema reported for all subjects participating in the study. The recurrence rate observed suggests that once daily dosing and 5×/week dosing yield similar clearance rates, but daily dosing increases local skin reactions.
Aldara Dosage : Drugs.com - 0 views
Aldara - 0 views
Imiquimod Side Effects | Drugs.com - 0 views
Aldara - 0 views
Aldara Side Effects | Drugs.com - 0 views
Aldara Information from Drugs.com - 0 views
« First
‹ Previous
41 - 60 of 60
Showing 20▼ items per page